Case Study

Cost Savings in Newly Diagnosed Glioblastoma Multiforme (GBM) Trial

Response Criteria: RANO
Site Geo: US
Phase: Il

A clinical stage biotechnology company launched a Phase II prospective clinical trial in patients with glioblastoma. Mid-study, MERIT was engaged to supply the high-quality imaging data and expertise needed to keep the study on track. MERIT’s robust cloud-based software platform, EXCELSIOR, and our operational experience enabled the project team to handle both retrospective and prospective imaging.


The study sites, CRO, and Sponsor all gained advantages from the implementation of EXCELSIOR. Specifically, the Sponsor profited from MERIT’s unique Collect & Hold (C&H) subscription model, which allows early-phase studies to realize the cost-savings of engaging with an experienced imaging vendor. The C&H model provides immediate benefit to a Sponsor’s current study, while also providing future benefits to a company’s drug program.

RESULT: Cost Savings

60% cost reduction associated with early phase Collect & Hold Project


MERIT has provided image collection, centralized reading, and data management services for clinical trials since 2012. Through innovative and proven technologies, alongside our intuitive, seamless workflows, MERIT’s experienced staff bring more than a decade of clinical endpoint expertise, ensuring the success and integrity of your clinical trials. You have choices for your endpoint services provider. MERIT values your  partnership and will make your study a priority.


E: | P: (608) 509-7122


Connect with us to learn more about how our expertise and approach can support bringing your product to market on-time and on-budget. Your success is our priority.